Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Aug-23 7:46 PM View:  | Koconis John CEO & Chairman | BioPharmX Corporation (TMBR) | 20-Aug-23 | Grant | 70,385 | -- | -- | 17596% 0.4K to 70.78K | |
| 22-Aug-23 7:43 PM View: | Lucchese Joseph EVP & CFO | BioPharmX Corporation (TMBR) | 20-Aug-23 | Grant | 35,193 | -- | -- | 100% 0 to 35.19K | |
| 22-Aug-23 7:45 PM View: | Mendelsohn Alan EVP & CMO | BioPharmX Corporation (TMBR) | 20-Aug-23 | Grant | 35,193 | -- | -- | 14725% 0.24K to 35.43K | |
| 18-Apr-23 11:33 AM View: | Sitar Edward J Director | BioPharmX Corporation (TMBR) | 15-Apr-23 | Grant | 5,327 | -- | -- | 92% 5.8K to 11.13K | |
| 18-Apr-23 11:41 AM View: | Gaal Lubor Director | BioPharmX Corporation (TMBR) | 15-Apr-23 | Grant | 4,100 | -- | -- | 205% 2.0K to 6.1K | |
| 18-Apr-23 11:35 AM View: | Pirozzi Gianluca Director | BioPharmX Corporation (TMBR) | 15-Apr-23 | Grant | 4,100 | -- | -- | 205% 2.0K to 6.1K | |
| 18-Apr-23 11:32 AM View: | Cohen David E Director | BioPharmX Corporation (TMBR) | 15-Apr-23 | Grant | 4,100 | -- | -- | 205% 2.0K to 6.1K | |
| 16-Dec-22 4:05 PM View: | Sitar Edward J Director | BioPharmX Corporation (TMBR) | 15-Dec-22 | Grant | 2,500 | $1.63 | $4,072.50 | 76% 3.3K to 5.8K | |
| 19-Apr-22 12:54 PM View: | Gaal Lubor Director | BioPharmX Corporation (TMBR) | 15-Apr-22 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 19-Apr-22 12:57 PM View: | Pirozzi Gianluca Director | BioPharmX Corporation (TMBR) | 15-Apr-22 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 19-Apr-22 12:59 PM View: | Cohen David E Director | BioPharmX Corporation (TMBR) | 15-Apr-22 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 19-Apr-22 12:58 PM View: | Sitar Edward J Director | BioPharmX Corporation (TMBR) | 15-Apr-22 | Grant | 150,000 | -- | -- | 1000% 15.0K to 165.0K | |
| 15-Apr-22 4:10 PM View: | Rome Zachary Director | BioPharmX Corporation (TMBR) | 04-Mar-22 | Option Exercise | 79,326 | $0.01 | $793.26 | 100% 0 to 79.33K | |
| 15-Apr-22 4:10 PM View: | Rome Zachary Director | BioPharmX Corporation (TMBR) | 04-Mar-22 | Payment of Exercise | 19,630 | $0.28 | $5,496.40 | (25%) 79.33K to 59.7K | |
| 16-Dec-21 4:23 PM View: | Koconis John CEO & President Director | BioPharmX Corporation (TMBR) | 15-Dec-21 | Market Purchase | 20,000 | $0.38 | $7,686.00 | 100% 0 to 20.0K | 7% |
| 24-Nov-21 4:11 PM View: | Mendelsohn Alan Chief Medical Officer | BioPharmX Corporation (TMBR) | 23-Nov-21 | Market Purchase | 10,000 | $0.47 | $4,700.00 | 503% 1.99K to 11.99K | (6%) |
| 24-Nov-21 4:07 PM View: | Sitar Edward J Director | BioPharmX Corporation (TMBR) | 23-Nov-21 | Market Purchase | 15,000 | $0.46 | $6,900.00 | 100% 0 to 15.0K | (4%) |
| 02-Sep-21 7:11 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 02-Sep-21 | Market Sale | 225,000 | $0.94 | $210,960.00 | (6%) 3.73M to 3.51M | < 1% |
| 01-Sep-21 5:29 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 01-Sep-21 | Market Sale | 150,500 | $0.92 | $138,866.00 | (4%) 3.88M to 3.73M | < 1% |
| 01-Sep-21 5:29 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 31-Aug-21 | Market Sale | 150,000 | $0.91 | $136,740.00 | (4%) 4.03M to 3.88M | (< 1%) |
| 01-Sep-21 5:29 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 30-Aug-21 | Market Sale | 100,000 | $0.93 | $92,660.00 | (2%) 4.13M to 4.03M | < 1% |
| 26-Aug-21 6:47 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 26-Aug-21 | Market Sale | 100,000 | $0.92 | $91,840.00 | (2%) 4.23M to 4.13M | (< 1%) |
| 26-Aug-21 6:47 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 25-Aug-21 | Market Sale | 100,000 | $0.91 | $91,260.00 | (2%) 4.33M to 4.23M | (< 1%) |
| 26-Aug-21 6:47 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 24-Aug-21 | Market Sale | 100,000 | $0.93 | $92,530.00 | (2%) 4.43M to 4.33M | 2% |
| 20-Aug-21 6:19 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 20-Aug-21 | Market Sale | 50,000 | $0.91 | $45,395.00 | (1%) 4.48M to 4.43M | (< 1%) |
| 20-Aug-21 6:19 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 19-Aug-21 | Market Sale | 50,000 | $0.95 | $47,700.00 | (1%) 4.53M to 4.48M | 5% |
| 20-Aug-21 6:19 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 18-Aug-21 | Market Sale | 75,000 | $1.00 | $75,075.00 | (2%) 4.61M to 4.53M | 9% |
| 15-Jun-21 6:49 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 15-Jun-21 | Market Sale | 28,450 | $1.26 | $35,923.80 | (< 1%) 4.64M to 4.61M | (2%) |
| 15-Jun-21 6:49 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 14-Jun-21 | Market Sale | 146,465 | $1.27 | $185,556.00 | (3%) 4.78M to 4.64M | (2%) |
| 10-Jun-21 6:06 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 10-Jun-21 | Market Sale | 185,229 | $1.26 | $233,926.00 | (4%) 4.97M to 4.78M | 3% |
| 10-Jun-21 6:06 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 09-Jun-21 | Market Sale | 96,481 | $1.27 | $122,907.00 | (2%) 5.07M to 4.97M | 3% |
| 10-Jun-21 6:06 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 08-Jun-21 | Market Sale | 305,540 | $1.29 | $393,383.00 | (6%) 5.37M to 5.07M | 4% |
| 02-Jun-21 5:57 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 02-Jun-21 | Market Sale | 9,879 | $1.26 | $12,447.50 | (< 1%) 5.38M to 5.37M | 0% |
| 02-Jun-21 5:57 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 01-Jun-21 | Market Sale | 8,670 | $1.26 | $10,951.90 | (< 1%) 5.39M to 5.38M | < 1% |
| 02-Jun-21 5:57 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 28-May-21 | Market Sale | 47,736 | $1.27 | $60,619.90 | (< 1%) 5.44M to 5.39M | < 1% |
| 13-May-21 4:06 PM View: | Mendelsohn Alan Chief Medical Officer | BioPharmX Corporation (TMBR) | 03-Mar-21 | Market Purchase | 1,988 | $2.17 | $4,313.96 | 100% 0 to 1.99K | (48%) |
| 16-Sep-20 5:38 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 16-Sep-20 | Market Sale | 100,694 | $1.03 | $103,695.00 | (2%) 5.54M to 5.44M | (9%) |
| 16-Sep-20 5:38 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 15-Sep-20 | Market Sale | 87,060 | $1.03 | $89,549.90 | (2%) 5.63M to 5.54M | (9%) |
| 16-Sep-20 5:38 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 14-Sep-20 | Market Sale | 455 | $1.03 | $468.65 | (< 1%) 5.63M to 5.63M | (9%) |
| 14-Sep-20 4:05 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 11-Sep-20 | Market Sale | 7,483 | $1.03 | $7,709.73 | (< 1%) 5.63M to 5.63M | (10%) |
| 14-Sep-20 4:05 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 10-Sep-20 | Market Sale | 32,943 | $1.04 | $34,379.30 | (< 1%) 5.67M to 5.63M | (8%) |
| 20-May-20 8:47 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 18-May-20 | Acquisition (other) | 5,666,150 | -- | -- | 100% 0 to 5.67M | |
| 12-Feb-20 7:28 PM View: | Timber Pharmaceuticals LLC 10% Owner | BioPharmX Corporation (TMBR) | 10-Feb-20 | Exercise (in-the money or at-the-money) | 2,255,340 | $0.01 | $22,553.40 | 100% 0 to 2.26M | |
| 12-Feb-20 7:28 PM View: | Timber Pharmaceuticals LLC 10% Owner | BioPharmX Corporation (TMBR) | 10-Feb-20 | Sale | 55,008 | $0.01 | $550.08 | (2%) 2.26M to 2.2M | |
| 12-Feb-20 7:24 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 10-Feb-20 | Sale Duplicate | 55,008 | $0.01 | $550.08 | (2%) 2.26M to 2.2M | |
| 12-Feb-20 7:24 PM View: | Tardimed Sciences LLC 10% Owner | BioPharmX Corporation (TMBR) | 10-Feb-20 | Exercise (in-the money or at-the-money) Duplicate | 2,255,340 | $0.01 | $22,553.40 | 100% 0 to 2.26M | |
| 27-Jun-19 5:00 PM View: | Vivo Capital Viii, LLC 10% Owner | BioPharmX Corporation (TMBR) | 25-Jun-19 | Market Sale | 327,870 | $1.02 | $334,427.00 | (51%) 645.14K to 317.27K | 90% |
| 25-Jan-19 6:55 PM View: | Krammer Anja B Director | BioPharmX Corporation (TMBR) | 23-Jan-19 | Market Sale | 115,874 | $0.11 | $12,746.10 | (6%) 2.0M to 1.88M | 97% |
| 22-Oct-18 6:39 PM View: | Morlock Stephen Director | BioPharmX Corporation (TMBR) | 22-Oct-18 | Market Sale | 220,766 | $0.18 | $39,737.90 | (47%) 471.84K to 251.07K | 98% |
| 22-Oct-18 6:39 PM View: | Morlock Stephen Director | BioPharmX Corporation (TMBR) | 22-Oct-18 | Market Sale | 251,071 | $0.18 | $45,192.80 | (100%) 251.07K to 0 | 98% |
